Sally John

Dr John is advising 5 Prime Sciences on human genetics strategy and translational drug discovery matters. Dr John is Head of Translational Biology at Biogen and previously held senior genetics and genomics leadership roles at Pfizer and AstraZeneca, with a PhD in Molecular Biology from the University of Manchester.